Increase in adoption of targeted immunotherapy, improved approval rate of therapeutic antibodies by regulatory authorities, and rise in R&D expenditure of pharmaceutical and biotechnology companies drive the growth of the global antibody production market. In addition, increase in incidence of infectious diseases and growth in demand for protein therapeutics fuel the market growth. However, high cost of primary antibodies restrains the market growth. Increase in R&D activities for the development of advanced antibodies and the growth in adoption of targeted immunotherapy are expected to provide opportunities for the market.

The global antibody production market is segmented by process, end user, and region. Based on process, the market is categorized into upstream processing, downstream processing, and filtration. The upstream processing segment is further divided into bioreactors and consumables.

Download Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/3573

The bioreactors segment is subdivided into large-scale bioreactors and single-use bioreactors, whereas consumables segment is subsegmented into media and buffers & reagents. The market by filtration is classified into filtration systems and filtration consumables & accessories. By end user, the market is classified into pharmaceutical & biotechnology companies, diagnostic laboratories, and research institutes. Geographically, it is analyzed across North America, Europe, Asia Pacific, and LAMEA.

The companies profiled in the report are GeneTex, Inc., Thermo Fisher Scientific, Inc., Eli Lilly and Company, Merck KGaA, Pall Corporation, Sigma-Aldrich Corporation, Eppendorf AG, Cellab GmbH, Abcam PLC, and FiberCell Systems Inc.

Key Benefits

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the global market.
Extensive analysis represents the use of antibody in the treatment of infectious diseases such as pneumonia, food poisoning, urethritis, and others.
Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3573

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

Toll Free (USA/Canada):

+1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1⟨855⟩550-5975

[email protected]

Web: https://www.alliedmarketresearch.com